Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fengwei Tan

Showing results (101-110 of 151) with videos related to

Pageof 16
Sort By:
Chinese Medical Journal Pulmonary and Critical Care Medicine|August 22, 2024
Disparities in the global burden of tracheal, bronchus, and lung cancer from 1990 to 2019Chenran Wang, Zheng Wu, Yongjie Xu, et al.
Cancer Letters|April 29, 2014
MiRNA expression profile reveals a prognostic signature for esophageal squamous cell carcinomaZhaoli Chen, Jiagen Li, Liqing Tian, et al.
Nature Communications|September 28, 2020
Integrated molecular characterization reveals potential therapeutic strategies for pulmonary sarcomatoid carcinomaZhenlin Yang, Jiachen Xu, Lin Li, et al.
NPJ Precision Oncology|December 10, 2020
Different pathologic responses to neoadjuvant anti-PD-1 in primary squamous lung cancer and regional lymph nodesYun Ling, Ning Li, Lin Li, et al.
Frontiers in Oncology|April 17, 2023
Effectiveness of neoadjuvant immunochemotherapy compared to neoadjuvant chemotherapy in non-small cell lung cancer patients: Real-world data of a retrospective, dual-center studyKailun Fei, Gang Guo, Jie Wang, et al.
BMC Medicine|November 22, 2021
m<sup>6</sup>A regulator expression profile predicts the prognosis, benefit of adjuvant chemotherapy, and response to anti-PD-1 immunotherapy in patients with small-cell lung cancerZhihui Zhang, Chaoqi Zhang, Yuejun Luo, et al.
Biochemical and Biophysical Research Communications|March 28, 2012
MicroRNA-25 promotes cell migration and invasion in esophageal squamous cell carcinomaXiaohui Xu, Zhaoli Chen, Xiaohong Zhao, et al.
Aging|January 20, 2021
The therapeutic significance of the novel photodynamic material TPE-IQ-2O in tumorsLiyu Wang, Yu Liu, Hengchang Liu, et al.
Thoracic Cancer|April 23, 2026
Radiological, Molecular, and Pathological Factors Unite: A Model for Predicting Recurrence-Free Survival in Pathological Stage I Lung AdenocarcinomaHui Zeng, Yufei Huang, Zehao Song, et al.
Cancer Letters|June 12, 2026
Plasma metabolomics enhances risk prediction for lung cancer: a population-based validation studyChenran Wang, Xuesi Dong, Guochao Zhang, et al.
Pageof 16

Showing results (101-110 of 151) with videos related to

Sort By:
Pageof 16
Chinese Medical Journal Pulmonary and Critical Care Medicine|August 22, 2024
Disparities in the global burden of tracheal, bronchus, and lung cancer from 1990 to 2019Chenran Wang, Zheng Wu, Yongjie Xu, et al.
Cancer Letters|April 29, 2014
MiRNA expression profile reveals a prognostic signature for esophageal squamous cell carcinomaZhaoli Chen, Jiagen Li, Liqing Tian, et al.
Nature Communications|September 28, 2020
Integrated molecular characterization reveals potential therapeutic strategies for pulmonary sarcomatoid carcinomaZhenlin Yang, Jiachen Xu, Lin Li, et al.
NPJ Precision Oncology|December 10, 2020
Different pathologic responses to neoadjuvant anti-PD-1 in primary squamous lung cancer and regional lymph nodesYun Ling, Ning Li, Lin Li, et al.
Frontiers in Oncology|April 17, 2023
Effectiveness of neoadjuvant immunochemotherapy compared to neoadjuvant chemotherapy in non-small cell lung cancer patients: Real-world data of a retrospective, dual-center studyKailun Fei, Gang Guo, Jie Wang, et al.
BMC Medicine|November 22, 2021
m<sup>6</sup>A regulator expression profile predicts the prognosis, benefit of adjuvant chemotherapy, and response to anti-PD-1 immunotherapy in patients with small-cell lung cancerZhihui Zhang, Chaoqi Zhang, Yuejun Luo, et al.
Biochemical and Biophysical Research Communications|March 28, 2012
MicroRNA-25 promotes cell migration and invasion in esophageal squamous cell carcinomaXiaohui Xu, Zhaoli Chen, Xiaohong Zhao, et al.
Aging|January 20, 2021
The therapeutic significance of the novel photodynamic material TPE-IQ-2O in tumorsLiyu Wang, Yu Liu, Hengchang Liu, et al.
Thoracic Cancer|April 23, 2026
Radiological, Molecular, and Pathological Factors Unite: A Model for Predicting Recurrence-Free Survival in Pathological Stage I Lung AdenocarcinomaHui Zeng, Yufei Huang, Zehao Song, et al.
Cancer Letters|June 12, 2026
Plasma metabolomics enhances risk prediction for lung cancer: a population-based validation studyChenran Wang, Xuesi Dong, Guochao Zhang, et al.
Pageof 16